VEEA Gaps 80% Pre-Market on NovaGen Merger Term Sheet — A Levels Guide to a 1.59M-Share Float

VEEA is gapping hard in Tuesday’s pre-market, September 15, and this time there’s an actual catalyst behind the tape. Monday after the close, Veea and NovaGen Group B.V., a personalized regenerative medicine and longevity company, announced they’ve signed a term sheet to combine, targeting a definitive business combination agreement within the coming weeks, with GeoNova Capital committing US$10 million as cornerstone institutional investor. The stock ripped after hours and carried the move into this morning’s session, trading well north of a quadruple off Friday’s close at points overnight.

Quick vocabulary lesson, because it matters for how you size this: a term sheet is not a merger. It’s a non-binding outline of intent. The definitive agreement, shareholder approvals, and closing conditions all still sit between here and an actual combined company. Deals at the term-sheet stage break all the time, and when they break, the entire premium can evaporate in one press release.

The catalyst — and the tell that preceded it

Veea itself sells edge computing infrastructure — the VeeaONE platform integrates connectivity, computing, cybersecurity and storage into a unified hyperconverged network solution, and the company holds more than 123 patents. The deal would bolt a longevity-clinic story onto that: a connected health platform called NovaGen Health Networks, with initial deployments beginning at NovaGen clinics and partner hospitals in Q4 2026.

One detail worth filing away: Monday’s regular session ran from a $1.60 open to a $2.29 close on tens of millions of shares — before the 4:42 PM ET press release hit. Somebody was buying size ahead of the news. Draw your own conclusions; just know the easy money positioned Monday morning.

The float math a reverse split built

This is where the move gets its violence. Veea executed a 1-for-20 reverse stock split effective August 28, with post-split trading beginning August 31, 2026. That compression is why the float now sits under 2 million shares — pre-market volume this morning already represents the float turning over more than a dozen times. Add reported short interest that grew sharply in August per recent short-interest updates, and you have squeeze kindling stacked on a merger headline.

The other side of the ledger: Veea burns cash — free cash flow was roughly negative $5.7 million last quarter against a market cap in the low teens of millions. A $10M commitment from GeoNova helps, but it arrives as part of a deal that isn’t signed yet, and outstanding warrants and other convertible securities were adjusted through the split and remain part of the structure. Financing risk hasn’t left the building.

The levels

• Resistance: the pre-market high near $4.40–4.45 is the ceiling that matters into the open. Clear it on volume and there’s little structure until the whole-number magnets at $5 and $6.
• Support: the overnight low around $3.30 is the line. Pre-market VWAP sits near $3.90 — holding above it says buyers still control the session; losing it points back toward $3.30.
• Failure zone: below $3.30, Monday’s $2.36 high is the gap-fill reference. A term-sheet gap that gives back its overnight range is a warning, not a dip.

Watch the first 30 minutes: sub-4M-float names either extend immediately on continued volume or fade to VWAP while early longs ring the register. Halts are near-certain either direction — size so a five-minute pause doesn’t force your hand. A signed definitive agreement is the second-act catalyst; a raise announcement or deal-talk breakdown is the trap door.

This is not investment advice; do your own research and manage your own risk.

The Setup: This is a Shell Merger play — read the pattern guide to learn how these setups typically unfold.